VectorY

News

VectorY has been cleared by the FDA to start human trials of a drug against a target implicated in up to 97% of amyotrophic lateral sclerosis cases.

News

The month of November saw a number of notable hires and personnel moves in biotech and

News

Shares in Tenax 85% of their value after its drug for patients with pulmonary hypertension caused by a form of heart failure flunked a phase 3 trial.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.